An eight-year-old Rottweiler starts favouring a front leg. He's a big dog, he's getting older, he flew off the sofa chasing a squirrel last week — the explanation writes itself. A course of anti-inflammatories helps for a fortnight. Then it doesn't. Then there's a firm swelling just above the wrist that wasn't there before.

That sequence is how osteosarcoma introduces itself in the overwhelming majority of cases, and the reason it matters so much is timing. Bone cancer in dogs is fast, painful and prone to spreading to the lungs before anyone knows it exists. The single most useful thing an owner can do is treat a limp that isn't resolving as a reason for an X-ray, not a reason for another two weeks of painkillers.

What Osteosarcoma Actually Does to Bone

Osteosarcoma is a malignant tumour arising from osteoblasts — the cells whose job is building bone. In healthy bone, building and breaking down are kept in careful balance. In an osteosarcoma, that balance collapses. The tumour destroys normal bone and replaces it with disorganised, structurally useless cancerous bone.

Two consequences follow directly from that. The first is pain, and it is severe. Bone is densely innervated, and the combination of tumour expansion, inflammation and microfractures produces one of the most painful conditions in veterinary medicine. The second is fragility: a bone hollowed out and replaced by tumour can snap under ordinary weight-bearing. These pathologic fractures are not repairable in the usual sense, and they're a genuine emergency.

Around three-quarters of cases are appendicular — in the limbs, and specifically at the ends of long bones near joints. The classic locations follow the old veterinary mnemonic "away from the elbow, towards the knee": the distal radius (just above the wrist), the proximal humerus (shoulder), the distal femur and the proximal tibia (around the stifle). Less often, osteosarcoma is axial, affecting the jaw, skull, ribs, spine or pelvis — and axial cases are far less restricted to large breeds.

Which Dogs Are at Risk — and How Strongly

Osteosarcoma is not a common disease overall. A VetCompass study of 905,552 UK dogs under veterinary care found 331 cases, a one-year frequency of just 0.037%. But that population-level figure hides an enormous spread between breeds.

The same study found the highest annual frequencies in Scottish Deerhounds (3.28%), Leonbergers (1.48%), Great Danes (0.87%), Rottweilers (0.84%) and Greyhounds (0.62%). Expressed as odds against crossbred dogs, Scottish Deerhounds were 118 times more likely to be diagnosed, Leonbergers 56 times, Great Danes 34 times and Rottweilers 27 times.

Body size is the dominant thread. Affected dogs had an average adult bodyweight of 33 kg versus 13.95 kg in unaffected dogs, and a separate UK case-control study found dogs over 40 kg had osteosarcoma odds more than 45 times those of dogs under 10 kg. Conformation matters too: long-muzzled (dolichocephalic) breeds carried 2.72 times the risk of medium-muzzled breeds, while flat-faced breeds had half the risk, and chondrodystrophic breeds with genetically shortened legs — Dachshunds, Corgis — had just a tenth of the risk.

Average age at diagnosis in that dataset was 9.64 years, though a smaller subset of dogs develop osteosarcoma as young adolescents. Rarely, tumours arise at the site of an old healed fracture, chronic bone infection, a metallic implant, or previous radiation exposure.

None of this means a Jack Russell can't get bone cancer — that breed sat at 0.05 times crossbred odds, low but not zero. It means that in a nine-year-old Great Dane with a limp, osteosarcoma belongs near the top of the list from the first appointment.

The Signs Worth Acting On

Early osteosarcoma is easy to mistake for a soft-tissue injury or arthritis. Watch for:

For jaw or skull tumours, the picture is different: facial swelling, difficulty eating, drooling or loose teeth. Rib tumours may show as a firm chest wall mass.

How It's Diagnosed

Diagnosis usually starts with radiographs of the affected bone. Osteosarcoma has a fairly characteristic radiographic appearance — bone lysis mixed with new bone production, a poorly defined transition zone, and periosteal reaction. Crucially, it typically respects the joint rather than crossing it, which helps distinguish it from infection.

X-rays raise strong suspicion; only biopsy or cytology confirms it. Some cases are diagnosed on a fine needle aspirate, others need a bone biopsy. Alongside that, your vet will want chest radiographs (or ideally CT) to look for lung metastases, plus bloodwork and urinalysis to assess overall fitness for treatment. CT of the affected limb is often used when limb-sparing surgery is being considered.

Here's the hard reality behind the staging: fewer than 15% of dogs have visible lung metastases at diagnosis, but the disease behaves as though nearly all of them already have microscopic spread. That assumption is the entire rationale for chemotherapy.

Treatment: What Each Option Really Buys

Pain control comes first and continues throughout, whatever else is chosen. NSAIDs, gabapentin, amantadine and opioids are used alone or in combination.

Amputation removes the tumour, eliminates the source of pain and removes the fracture risk. It does not slow the spread of cancer. Median survival with amputation alone is around four months, and roughly 10% of dogs reach a year.

Amputation plus chemotherapy is the standard of care. Carboplatin given intravenously every three weeks over four to five months is the usual protocol, aimed at delaying metastasis. This roughly doubles survival: median survival is around nine months to a year, with about 20% of dogs alive beyond two years. Dogs generally tolerate veterinary chemotherapy far better than people expect — doses are calibrated for quality of life rather than maximum tolerated intensity, and severe side effects are uncommon.

Limb-sparing surgery removes the affected bone segment and reconstructs the limb. It suits selected cases — mainly distal radius tumours — but a 2025 consensus review notes it has not been shown to produce better survival than amputation with chemotherapy, and complication rates including infection are significant.

Stereotactic radiation therapy (SRT) delivers a very high, precisely targeted radiation dose over one to three sessions and can preserve the limb in carefully chosen dogs. Fracture of the treated bone is the main risk.

Palliative radiation and bisphosphonates are the route when surgery is declined or impossible. Hypofractionated radiation gives useful pain relief in a majority of dogs, and IV bisphosphonates such as pamidronate or zoledronate reduce bone destruction and pain. This path prioritises comfort over duration, and for many families it is the right decision.

Immunotherapy remains investigational. Several approaches have produced encouraging results in small studies, and clinical trials are open at many teaching hospitals — worth asking your oncologist about.

Living on Three Legs

The prospect of amputating a large dog's leg is, for most owners, the hardest part of the conversation. The evidence and clinical experience are consistent and reassuring: most dogs adapt within days to a few weeks and return to normal activity, and owners overwhelmingly report good to excellent quality of life afterwards. Removing a bone tumour removes constant, severe pain, and many dogs are visibly more comfortable than they were before surgery.

Adaptation is harder for dogs who are very overweight, who have significant osteoarthritis or neurological disease in the remaining limbs, or who are extremely large. Front-limb amputation is generally more demanding than hind, because the forelimbs carry about 60% of a dog's weight. Weight management, rehabilitation, non-slip flooring and a harness with a handle all help.

What to Take Away

There is no cure for canine osteosarcoma, and no article should pretend otherwise. What treatment offers is time and — just as importantly — freedom from a genuinely brutal pain. Some families pursue amputation and chemotherapy; others choose palliative care from the outset. Both are defensible, and the right answer depends on the individual dog, the family and the resources available.

What isn't defensible is another month of painkillers for a limp that isn't getting better. If your dog is large, middle-aged or older, and lame in one leg for more than a couple of weeks, ask for an X-ray. It's a quick, inexpensive test, and in bone cancer the difference between a dog with options and a dog with a fractured femur is often measured in weeks.